Omnicell, Inc. announced it has increased its number of board seats from 9 to 10, and has appointed Kaushik âBobbyâ Ghoshal to fill the newest seat as an independent director of Omnicellâs Board of Directors, effective immediately. Mr. Ghoshal is an established technology leader who brings more than 30 years of experience across multiple industries including finance, semiconductors, and healthcare. In Mr. Ghoshalâs current role as President of SaaS for ResMed, Inc. (âResMedâ), he leads the Companyâs global software business and is responsible for the vision, strategy, and day-to-day operations of the Companyâs rapidly expanding SaaS portfolio.
Prior to this, he served as ResMedâs Chief Technology Officer. He has also served as Chief Operating Officer of Brightree LLC, a ResMed-owned provider of cloud-based SaaS for out-of-hospital care. The addition of Mr. Ghoshal to Omnicellâs Board is part of the Boardâs ongoing refreshment process, which has resulted in the addition of five new directors in the last four years.
In connection with his appointment, Mr. Ghoshal will join the Boardâs Corporate Governance Committee. The Board now comprises 10 directors, 9 of whom are independent and all of whom bring a broad range of skills and experience that enhance the Boardâs ability to effectively fulfill its governance and oversight responsibilities.